Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
March 13, 2018 | Contemporary OB/GYN
New data on vaginal ring support benefits for HIV prevention
Interim data from two studies of a dapivirine vaginal ring—DREAM and HOPE—lend further credence to the potential benefits of using the device for HIV prevention More »
March 10, 2018 | FirstWord Pharma
Dapivirine Vaginal Ring Is Reducing Risk of HIV Infection Among Women in Serodiscordant Relationships: Presented at CROI
The HOPE study launched in August of 2016 as an extension of the phase 3 ASPIRE clinical trial. More »
March 09, 2018 | Healio / Infectious Disease News
Open-label studies show high uptake of vaginal ring for HIV prevention
“The data support the development of the ring as a potentially important new prevention option for women, who continue to bear the brunt of the epidemic and still lack a range of options that they... More »
March 08, 2018 | Medscape
HIV Incidence Drops Below 2% in Vaginal Ring Follow-ups
Women who used a dapivirine vaginal ring for HIV prevention were infected at a rate of less than 2%, according to interim data from the concurrent HOPE and DREAM extension trials. More »
March 08, 2018 | Contagion LIVE
Dapivirine Ring Shown to Reduce HIV-Risk in Women by 54%
The preliminary results have revealed that the reduction in the risk of HIV infection is even better in the HOPE trial than the other 2 trials, and women’s use of this new form of HIV protection is... More »